cholestane-3,5,6-triol has been researched along with probucol in 1 studies
| Studies (cholestane-3,5,6-triol) | Trials (cholestane-3,5,6-triol) | Recent Studies (post-2010) (cholestane-3,5,6-triol) | Studies (probucol) | Trials (probucol) | Recent Studies (post-2010) (probucol) |
|---|---|---|---|---|---|
| 83 | 0 | 20 | 1,488 | 174 | 317 |
| Protein | Taxonomy | cholestane-3,5,6-triol (IC50) | probucol (IC50) |
|---|---|---|---|
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, T; Hesong, Z; Kaneko, E; Kinoshita, M; Nakazawa, T; Shimokado, K; Xui, N; Yui, K | 1 |
1 other study(ies) available for cholestane-3,5,6-triol and probucol
| Article | Year |
|---|---|
Danshen inhibits oxysterol-induced endothelial cell apoptosis in vivo.
Topics: Animals; Antioxidants; Aorta; Apoptosis; Cell Culture Techniques; Cholestanols; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Endothelial Cells; Humans; Hypolipidemic Agents; Injections, Intravenous; Male; Phenanthrolines; Probucol; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Umbilical Veins | 2005 |